Literature DB >> 19394000

Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society.

Bulent O Yildiz1, Ricardo Azziz.   

Abstract

Significant advances have been made in our understanding of ovarian dysfunction in polycystic ovary syndrome (PCOS), and alterations in adipose tissue function are likely to play an important role in its pathophysiology. This review highlights the principal novel concepts presented at the 4th special scientific meeting of the Androgen Excess and PCOS Society, "Ovarian and Adipose Tissue Dysfunction: Potential Roles in Polycystic Ovary Syndrome," which occurred on June 6, 2008 in San Francisco, California. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2009        PMID： 19394000      PMCID： PMC3727143          DOI： 10.1016/j.fertnstert.2009.03.058

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  23 in total

1.  Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome.

Authors:  Marta Cortón; José I Botella-Carretero; Alberto Benguría; Gemma Villuendas; Angel Zaballos; José L San Millán; Héctor F Escobar-Morreale; Belén Peral
Journal:  J Clin Endocrinol Metab       Date:  2006-10-24       Impact factor: 5.958

2.  Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance.

Authors:  Enrico Carmina; Salvo Bucchieri; Antonella Esposito; Antonio Del Puente; Pasquale Mansueto; Francesco Orio; Gaetana Di Fede; Giovambattista Rini
Journal:  J Clin Endocrinol Metab       Date:  2007-04-03       Impact factor: 5.958

3.  Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome.

Authors:  Enrico Carmina; Salvo Bucchieri; Pasquale Mansueto; GiovamBattista Rini; Michel Ferin; Rogerio A Lobo
Journal:  Fertil Steril       Date:  2008-05-02       Impact factor: 7.329

4.  Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry.

Authors:  Marta Cortón; José I Botella-Carretero; Juan A López; Emilio Camafeita; José L San Millán; Héctor F Escobar-Morreale; Belén Peral
Journal:  Hum Reprod       Date:  2007-12-22       Impact factor: 6.918

Review 5.  The reproductive phenotype in polycystic ovary syndrome.

Authors:  R Jeffrey Chang
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-10

6.  Effects of spironolactone on glucose transport and interleukin-6 secretion in adipose cells of women.

Authors:  A Corbould
Journal:  Horm Metab Res       Date:  2007-12       Impact factor: 2.936

Review 7.  Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome.

Authors:  David H Abbott; Rao Zhou; Ian M Bird; Daniel A Dumesic; Alan J Conley
Journal:  Endocr Dev       Date:  2008

8.  Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.

Authors:  Bee K Tan; Dennis Heutling; Jing Chen; S Farhatullah; Raghu Adya; Stephen D Keay; C Richard Kennedy; Hendrik Lehnert; Harpal S Randeva
Journal:  Diabetes       Date:  2008-03-28       Impact factor: 9.461

9.  Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?

Authors:  Yrsa Bergmann Sverrisdóttir; Tove Mogren; Josefin Kataoka; Per Olof Janson; Elisabet Stener-Victorin
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-01-15       Impact factor: 4.310

Review 10.  Abdominal adiposity and the polycystic ovary syndrome.

Authors:  Héctor F Escobar-Morreale; José L San Millán
Journal:  Trends Endocrinol Metab       Date:  2007-08-10       Impact factor: 12.015
View more
  6 in total

Review 1.  Current knowledge of obesity's effects in the pre- and periconceptional periods and avenues for future research.

Authors:  Emily S Jungheim; Kelle H Moley
Journal:  Am J Obstet Gynecol       Date:  2010-08-24       Impact factor: 8.661

2.  State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).

Authors:  David H Geller; Danièle Pacaud; Catherine M Gordon; Madhusmita Misra
Journal:  Int J Pediatr Endocrinol       Date:  2011-08-26

3.  Gene expression in subcutaneous adipose tissue differs in women with polycystic ovary syndrome and controls matched pair-wise for age, body weight, and body mass index.

Authors:  Louise Mannerås-Holm; Anna Benrick; Elisabet Stener-Victorin
Journal:  Adipocyte       Date:  2014-04-04       Impact factor: 4.534

4.  Influence of Maternal Diet and Intergenerational Change in Diet Type on Ovarian and Adipose Tissue Morphology in Female Rat Offspring.

Authors:  Nenad Čekić; Anđela Grgić; Antonio Kokot; Robert Mujkić; Darija Šnajder Mujkić; Nikola Bijelić; Marko Sablić
Journal:  Medicina (Kaunas)       Date:  2022-06-26       Impact factor: 2.948

5.  Irisin reduces the abnormal reproductive and metabolic phenotypes of PCOS by regulating the activity of brown adipose tissue in mice†.

Authors:  Yajing Zheng; Juan He; Dongyong Yang; Mengqin Yuan; Shiyi Liu; Fangfang Dai; Yifan Jia; Yanxiang Cheng
Journal:  Biol Reprod       Date:  2022-10-11       Impact factor: 4.161

Review 6.  The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy.

Authors:  Eduardo Spinedi; Daniel P Cardinali
Journal:  Int J Endocrinol       Date:  2018-07-25       Impact factor: 3.257
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.